The purpose of this study is to compare the efficacy of parecoxib with placebo on the incidence and severity of postthoracotomy shoulder pain, the amount of analgesic requirement for relieving severity of postthoracotomy shoulder pain and adverse events associated with treatment.
The incidence of Post-operative Ipsilateral Shoulder Pain (PISP) varies from 21-97% after thoracic surgery, despite receiving effective thoracic epidural analgesia. This pain has been described as constant, aching in quality, unrelated to position change or respiration. Possible causes of shoulder pain includes injury of the phrenic nerve, the lateral decubitus position, transection of major bronchus or preexisting arthritis condition. The possibilities of prevention and management of PISP are taken into consideration. Thoracic epidural block will be performed in all patients before general anesthesia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
160
Department of Anesthesiology, Faculty of Medicine, Chiang Mai University
Maung, Chiang Mai, Thailand
Department of Anesthesiology, Faculty of Medicine
Maung, Chiang Mai, Thailand
Numeric rating scale (NRS) of shoulder pain and incisional pain at rest and movement
Time frame: at 2 ,6 ,12 ,24 ,48,72 and 96 hours after the operation
compare an amount of morphine consumption
Time frame: at 2,6 ,12,24,48,72 and 96 hours after the operation
adverse effect related to parecoxib
Time frame: during 96 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.